Cody Stubblefield, RN, OCN, works in the cancer infusion center at Vanderbilt-Ingram Cancer Center. He is one of the latest Vanderbilt Health DAISY Award winners.

Ashley Colburn, BSN, RN, works at the Vanderbilt-Ingram Cancer Center Belle Meade. She is one of the latest Vanderbilt Health DAISY Award winners.

Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T.

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

Study showed that the improvement in lung cancer screenings exceeded the target enrollment set by the researchers.

Vanderbilt-Ingram Cancer Center serves more than 49,000 distinct patients and manages over 250,000 outpatient visits annually.